liposomal glutathione randomized controlled trial bioavailability Supplement Enhancing the Oral Bioavailability of

Disclosures: Arunkumar Krishnan: Nothing to Disclose, Diptasree Mukherjee: Nothing to Disclose, Carolin Schneider: Nothing to Disclose, Tinsay Woreta: Nothing to Disclose, Saleh Alqahtani: Nothing to Disclose 1624 SAROGLITAZAR IS MORE EFFECTIVE THAN SIMVASTATIN IN REDUCING STEATOSIS IN PATIENTS WITH MET-ALD Anand Kulkarni 1 Ramyasri Ramagundam 2 Zaid Mohammed Gangdany 2 Mithun Sharma 3 Manasa Alla 2 Shantan Venishetty 2 Sowmya T R 2 Padaki Nagaraja Rao 2 Nageshwar Reddy 2 , 1 Asian Institute of Gastroenterology, 2 AIG Hospitals, 3 ASIAN INSTITUTE OF GASTROENTROLOGY PVT LTD Background: MetALD is the new term proposed to identify patients with steatotic liver disease, who concomitantly consume alcohol (210-420 g/week)

Total spot polarization improved in both groups, and total skin tone improvement was slightly greater in the glutathione supplement group than in the placebo group, although this difference did not reach statistical significance

H.ReuterS.AggarwalB

In response to bile acid receptor activation, CSE is phosphorylated via the Akt pathway, which increases its catalytic activity (Renga et al ., 2015)